FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to immunology and oncologic urology. Efficiency prediction of interferon therapy in kidney cancer. Prior to interferon therapy blood lymphocytes of patient with kidney cancer is tested for glucose 6-phosphate dehydrogenase enzyme activity indicator. If this indicator is above 3.11 mcE/10000 lymphocytes positive effect of interferon therapy is predicted.
EFFECT: ability to predict interferon therapy efficiency in kidney cancer before treatment.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF INTERFERON SENSITIVITY IN PATIENTS SUFFERING RENAL CELL CARCINOMA | 2010 |
|
RU2437101C1 |
| METHOD FOR ESTIMATING RENAL CARCINOMA PATIENT SENSITIVITY TO INTERFERON | 2005 |
|
RU2293988C2 |
| METHOD FOR INDIVIDUALLY SELECTING AND ADJUSTING INTERFERON DOSE IN RENAL CARCINOMA PATIENTS | 2005 |
|
RU2314123C2 |
| METHOD FOR CARRYING OUT INTERFERON THERAPY | 1995 |
|
RU2105566C1 |
| METHOD OF ARRESTING HEPATITE "C" CHRONISATION | 2007 |
|
RU2331436C1 |
| METHOD FOR PREDICTING EFFICIENCY OF INTERFERONOTHERAPY AT CHRONIC HEPATITIS B | 2005 |
|
RU2287826C1 |
| METHOD OF TREATING METASTASES OF RENAL CELL CARCINOMA | 2009 |
|
RU2397777C1 |
| METHOD FOR PREDICTING THE RESULTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS C WITH INTERFERON-ALPHA PREPARATIONS | 2005 |
|
RU2287825C1 |
| METHOD OF TREATMENT OF DISSEMINATED RENAL CELL CANCER | 2017 |
|
RU2681300C1 |
| METHOD FOR TREATMENT OF HEMORRHAGIC FEVER WITH RENAL SYNDROME | 2002 |
|
RU2228196C1 |
